Lifecycle Flows Measured Against a Permanent Holdout

Quenby ChannelProNew0 orders on this service
Email, SMS and Lifecycle · Welcome, abandoned-cart and win-back flows

Welcome, abandonment and win-back flows built against a permanent five per cent holdout, so the number reported is incremental rather than attributed.

About this service

Every flow we build ships with a permanent holdout, five per cent of eligible profiles who never receive it, and the number we report each month is the gap between the two groups rather than what the ESP attributes. Across the last four programmes we inherited, attributed revenue overstated incremental revenue by between 2.1 and 4.6 times. Abandoned cart is the usual offender: most of the people it recovers were coming back anyway, and the flow was invoicing itself for their return. Welcome: The first message confirms what was consented to and when the next one arrives. The second message is almost always the one that earns, and most welcome sequences are built the other way round. For healthcare professional audiences the welcome is where credential verification happens; until it clears, the profile sits in a restricted state and receives nothing gated to HCPs, which is a data model decision as much as a content one. For a pet nutrition brand the welcome's job is to get the animal on file, species, age, weight band and dietary restriction, because every later message is worth more or less depending on whether that exists. Abandonment: Browse, cart and checkout are three different intents and deserve three different amounts of nerve. Where a brand sells on subscription or replenishment, we usually cut the third abandonment message entirely and put the effort into the replenishment trigger, which is where the money actually was. Timing is set against the observed return-visit curve for that brand, not against a round number of hours borrowed from a conference talk. Reply handling: On patient-facing programmes the reply-to address is a monitored intake channel, not a no-reply. Any reply naming a suspected side effect is routed to pharmacovigilance the same business day under a written procedure we agree with your safety team before the first send goes out. A lifecycle programme that cannot receive that reply is a compliance exposure with a discount code attached to it. Win-back and sunset: Win-back is a suppression decision before it is a campaign. Our default: no engagement in one hundred and eighty days drops a profile to a reduced cadence, and at three hundred and sixty-five days it is suppressed. The inbox placement recovered from cutting that tail is generally worth more than the sends given up, and we show that with the holdout instead of asserting it. Discounting is not the opening move in a win-back, and if it is the only move that works, the problem is the product or the price and we will say so in writing. What we refuse: Adding another message to a flow that has never been measured against a holdout. Reactivation aimed at addresses that have never engaged and whose consent nobody can evidence. Bolting SMS onto a flow on the strength of an email opt-in. And building a flow on data the brand does not yet collect, a request we get monthly, which is an instrumentation project wearing a lifecycle costume. Not for: Brands sending under about fifteen thousand messages a month. A holdout at that volume takes a year to say anything useful, and you should run your flows on judgement and spend the fee somewhere it works harder. Teams who want the flows live in three weeks. And anyone who needs the number in the monthly report to go up whether or not it went up in the bank.

Scope

Target market
Worldwide, Ireland
Working language
English
Industry
Ecommerce and DTC, Banking and insurance, Pharma and medtech, Pets
Engagement model
One-off project
Turnaround
1 month or more
Seller type
Boutique agency

What the seller needs from you

  1. 1What are your current flows, and what does the ESP report each of them earned last month?
  2. 2Monthly send volume and list size, split by market if you send to more than one.
  3. 3What behavioural data reaches the ESP today, and what only exists in your warehouse or backend?
  4. 4For patient or HCP audiences: who receives an adverse event report, and within what deadline?
  5. 5Who has authority to approve a flow going live, and does that include compliance or medical review?

Asked at checkout. Delivery time starts once you answer, not when you pay.

Reviews

No reviews on this service yet.

Reviews appear only after an order completes, and both sides review each other. Nothing here is seeded or bought.

Other sellers offering welcome, abandoned-cart and win-back flows

See all →

Starting at €8,000